Log in to save to my catalogue

A phase 1, single-blind, placebo-controlled, 3-arm cross-over trial assessing the appetite enhancing...

A phase 1, single-blind, placebo-controlled, 3-arm cross-over trial assessing the appetite enhancing...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2410983649

A phase 1, single-blind, placebo-controlled, 3-arm cross-over trial assessing the appetite enhancing effects of potentially ghrelinergic dairy-derived peptides

About this item

Full title

A phase 1, single-blind, placebo-controlled, 3-arm cross-over trial assessing the appetite enhancing effects of potentially ghrelinergic dairy-derived peptides

Publisher

Cambridge, UK: Cambridge University Press

Journal title

Proceedings of the Nutrition Society, 2020, Vol.79 (OCE2), Article E121

Language

English

Formats

Publication information

Publisher

Cambridge, UK: Cambridge University Press

More information

Scope and Contents

Contents

Methods to stimulate appetite in the sick or elderly remains a challenge with few safe therapeutic options. Ghrelin is an orexigenic hormone, increasing appetite and subsequent food intake. It has received considerable attention as a therapeutic target to stimulate food intake in patients with anorexia. The identification of food-grade bioactives w...

Alternative Titles

Full title

A phase 1, single-blind, placebo-controlled, 3-arm cross-over trial assessing the appetite enhancing effects of potentially ghrelinergic dairy-derived peptides

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2410983649

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2410983649

Other Identifiers

ISSN

0029-6651

E-ISSN

1475-2719

DOI

10.1017/S0029665120000695

How to access this item